Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures
Myelinoclastic diffuse sclerosis (MDS; also termed Schilder’s disease) is a rare inflammatory demyelinating disorder of the central nervous system characterised by demyelination of vast areas of the white matter. It is unclear whether MDS is a variant of multiple sclerosis (MS) or a disease entity i...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 February 2019
|
| In: |
Journal of neuroinflammation
Year: 2019, Volume: 16 |
| ISSN: | 1742-2094 |
| DOI: | 10.1186/s12974-019-1425-4 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12974-019-1425-4 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12974-019-1425-4 
|
| Author Notes: | S. Jarius, J. Haas, F. Paul and B. Wildemann |
| Summary: | Myelinoclastic diffuse sclerosis (MDS; also termed Schilder’s disease) is a rare inflammatory demyelinating disorder of the central nervous system characterised by demyelination of vast areas of the white matter. It is unclear whether MDS is a variant of multiple sclerosis (MS) or a disease entity in its own right. |
|---|---|
| Item Description: | Gesehen am 07.03.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1742-2094 |
| DOI: | 10.1186/s12974-019-1425-4 |